ARTICLE | Company News
Amylin, MDRNA deal
February 9, 2009 8:00 AM UTC
MDRNA (formerly Nastech Pharmaceutical Co. Inc.) received a $1 million milestone payment from Amylin under a 2006 deal to develop a nasal formulation of Amylin's exenatide. The payment was triggered ...